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Electron microscopy (EM) is a technology that enables visualization of single proteins at a nanometer
resolution. However, current protein analysis by EMmainly relies on immunolabeling with gold-parti-
cle-conjugated antibodies, which is compromised by large size of antibody, precluding precise detec-
tion of protein location in biological samples. Here, we develop a specific chemical labelingmethod for
EM detection of proteins at single-molecular level. Rational design of a-helical peptide tag and probe
structure provided a complementary reaction pair that enabled specific cysteine conjugation of the
tag. The developed chemical labeling with gold-nanoparticle-conjugated probe showed significantly
higher labeling efficiency and detectability of high-density clusters of tag-fused G protein-coupled
receptors in freeze-fracture replicas compared with immunogold labeling. Furthermore, in ultrathin
sections, the spatial resolution of the chemical labeling was significantly higher than that of anti-
body-mediated labeling. These results demonstrate substantial advantages of the chemical labeling
approach for single protein visualization by EM.1Graduate School of
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Electron microscopy (EM) is a powerful technique for detecting localization and distribution of a protein of
interest (POI) in biological specimens at a nanometer resolution. The most common approach in EM detec-
tion of POI is immunogold labeling, in which POI is specifically labeled with a high-electron-density gold
particle by using specific antibodies (Faulk and Taylor, 1971). However, immunogold labeling usually suf-
fers from inherent problems, which are mainly associated with the large molecular size of antibody
(ca. 150 kDa). First, the use of bulky primary and secondary antibodies locates gold particles 20–30 nm
away from POI (Fijita et al., 2007), precluding precise detection of protein localization in biological samples.
Second, the bulkiness of antibody limits simultaneous labeling of different components of a protein com-
plex. Since numerous proteins function by forming permanent or transient protein complexes in living cells
(Srihari et al., 2015; Havugimana et al., 2012), this limitation dramatically diminishes the utility of EM in pro-
tein analysis. Third, the large molecular size of antibody hinders its penetration into biological specimens,
making it challenging to quantitatively compare POI localization along tissue depth (Masugi-Tokita and
Shigemoto, 2007). Fourth, the development of an antibody that is highly selective toward POI is often tech-
nically demanding. Chemical protein labeling methods using small molecular probe could potentially
overcome these problems. However, despite their extensive use in fluorescence imaging, application to
single-protein detection by EM is yet to be reported.
Themethod for covalent labeling of proteins with a synthetic chemical probe enables functional analyses of
POI under biological conditions. Various protein labeling methods have been devised over the past 20
years and mainly used for fluorescence imaging of POI under live cell conditions (Xue et al., 2015; Dean
and Palmer, 2014; Krall et al., 2016). Among them, specific cysteine conjugation using reactive peptide
tag-probe pair has attracted considerable attention (Schneider and Hackenberger, 2017; Lotze et al.,
2016). The pioneering work of Tsien and co-workers led to the development of a method employing a
genetically encoded short peptide tag (CysCysXXCysCys) and a biarsenical probe (Griffin et al., 1998).
Since then, several peptide tag-based approaches, including oligohistidine tag (His6–10) (Martos-Maldo-
nado et al., 2018; Uchinomiya et al., 2013), p-clamp (Phe-Cys-Pro-Phe) (Zhang et al., 2016), and CX10R7 tag
(VTNQECCSIPM) (Ramil et al., 2016), have been devised for specific protein labeling. As a different256 iScience 22, 256–268, December 20, 2019 ª 2019 The Author(s).
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Figure 1. Specific Labeling of Protein Utilizing Complementary Recognition Pair of Peptide Tag and Reactive Zinc Complex
(A) Schematic illustration of covalent labeling of tag-fused protein with zinc complex probe.
(B) Binding-induced cysteine conjugation of a-helical peptide tag with zinc complex probe developed in the current study.
(C) Sequences of the peptide tags.
(D) Structures of the Zn(II)-DpaTyr probes.approach, various enzyme-mediated labeling methods for tag-fused proteins (SNAP-tag, Halo-tag, and
lipoic acid ligase) have also been developed (Walper et al., 2017). Compared with these enzymatic ap-
proaches, the chemical labeling methods using the tag-probe pair benefit from high tolerability of labeling
conditions (including pH, solvent composition, chemical fixation), flexibility in probe design independent
from substrate specificity of enzymes, and small molecular size of the tag and the probe, which allows loca-
tion of the labeled probe at close position to POI. All these properties would increase utility of the chemical
labeling method in high-resolution protein analysis by EM, which often needs to handle chemically fixed
cell and tissue.
We have previously reported the selective covalent labeling of protein using a complementary recognition
pair of a peptide tag and a reactive zinc complex (Figure 1A) (Nonaka et al., 2010). In this tag-probe pair, the
interaction between the aspartate-rich peptide tag (D4-tag; CAAAAAADDDDGDDDD) and the
tetranuclear zinc complex (Zn(II)-DpaTyr) induces their cysteine conjugation. However, the overly reactive
a-chloroacetamide group of the zinc complex often induced non-specific labeling, hampering its wide use
in fluorescence analysis of proteins. This problem prompted us to develop a new tag-probe pair, which has
an improved labeling selectivity while retaining a high reactivity. In this manuscript, we report the develop-
ment of a new peptide tag-probe pair for specific protein labeling and its application to EM detection of
membrane proteins at single-molecular level. The high labeling selectivity of this chemical labeling over-
came the problem of the non-specific labeling, enabling EM detection of the labeled G protein-coupled
receptor (GPCR) in cell membrane freeze-fracture replicas and ultrathin sections. The efficiency and reso-
lution obtained by the chemical labeling was significantly higher than those obtained by the immunogold
labeling. The chemical labeling method also revealed high-density clusters of molecules closer than a few
nanometers to each other, demonstrating its utility in single protein detection by EM.
RESULTS AND DISCUSSIONS
Design of a-Helical Peptide Tag
The selective chemical labeling of proteins would be achieved by utilizing a pair of highly reactive peptide
tag and probe with a tuned weak reactivity. On the basis of this strategy, we initially developed a highlyiScience 22, 256–268, December 20, 2019 257
Figure 2. Binding and Reactivity Profiles of Aspartate-Rich Peptide Tags
(A) CD spectral change of peptide-a upon the addition of 1-2Zn(II). Conditions: [peptide-a] = 50 mM, [1-2Zn(II)] = 0, 25, 50, and 100 mM, 10 mM borate buffer,
pH 8.0, 25C.
(B) Fluorescence titration profile of peptide-b (lem = 448 nm) upon the addition of 2-4Zn(II). Conditions: [peptide-b] = 0.05 mM, 50 mMHEPES buffer, 100 mM
NaCl, pH 7.2, 25C. Each plot represents the average value Gstandard error of triplicate experiments.
(C) Time-trace plot of the reaction of peptide-d with fluorogenic mCBI in the presence or absence of 2-4Zn(II). Conditions: [peptide-d] = 4 mM, [mCBI] =
120 mM, [2-4Zn(II)] = 14 mM, 50 mM HEPES, 100 mM NaCl, pH 7.2, 37C.
(D) Plot of pH-dependent reaction rate (Vo, DF) of peptide-d with mCBI in the presence or absence of 2-4Zn(II). Data were analyzed using Henderson-
Hasselbach equation.reactive peptide tag with a low pKa value of the cysteine residue. The pKa value of a cysteine thiol is typically
around 8.5, which indicates that the cysteine residue mainly exists as a weakly reactive sulfhydryl form
(R-SH) under neutral physiological conditions (pH = ca. 7.4). It is known that an N-terminal cysteine residue
of an a-helix possesses a low pKa value because of the strong electric dipole moment along the helical axis
(Figure 1B) (Kortemme and Creighton, 1995). On this basis, we initially designed peptide-a with four aspar-
tates at i, i+4 position (Figure 1C). Conformational change of peptide-a upon interaction with the binuclear
zinc complex 1-2Zn(II) (Figure 1D) was analyzed by circular dichroism (CD) (Figure 2A). Peptide-a existed as
a random coil in native state, as indicated by the CD spectrum (10 mM borate buffer, pH 8.0). However,
upon the addition of 1-2Zn(II), the characteristic signals of a-helix were observed at 190, 208, and
222 nm in the CD spectrum, with a concomitant appearance of the induced CD (i-CD) peaks at 264 and
303 nm in the absorption region of 1-2Zn(II). A similar CD signal was also induced by the dimer-type zinc
complex 2-4Zn(II) (Figure S1). The binding affinity of 2-4Zn(II) to peptide-a was estimated to be 1.37 3
107 M1by fluorescence titration of peptide-b, bearing a fluorescent 7-hydroxycoumarin (7-hc) (Figure 2B).
This binding affinity was approximately 2000-fold higher than that of the binuclear 1-2Zn(II) and the short
peptide-c (Ka= 7.043 10
3M1), as determined by isothermal titration calorimetrymeasurement (Figure S2).
These data suggested that multiple coordination interactions cooperatively work in the binding complex of
2-4Zn(II) and peptide-a to afford the strong binding affinity.
Design of Peptide Tag with a Highly Reactive Cysteine
We next evaluated the pKa value of the cysteine residue in the aspartate-rich peptides by using fluorogenic
monochlorobimane (mCBI). As shown in Figure 2C, the initial reaction rate of the peptide-d with mCBI
(Vo,DF, min
1) increased with rising pH (Figure 2D), and the analysis of the pH-dependent plot using Hen-
derson-Hasselbalch equation determined its cysteine pKa value to be 8.89 (Table 1) (Bulaj et al., 1998).
Interestingly, this pKa value decreased to 7.94 in the presence of 2-4Zn(II), suggesting that the a-helical
conformation induced by 2-4Zn(II) stabilized the thiolate anion due to the helix dipole moment.
We then modified the sequence of peptide-d to lower the pKa of the cysteine thiol. It is known that the fam-
ily of glutaredoxin proteins share a common -Cys-Pro-Xaa-Cys- motif in the active site and that the cysteine
thiol positioned at the N terminus of an a-helix has an extremely low pKa value (ca. 3.8) (Jao et al., 2006;
Floppe and Nilsson, 2007). On this basis, we designed peptide-e (Table 1) with an N-terminal -Cys-Pro-
Tyr-Ala- sequence mimicking yeast glutaredoxin. The pKa of the cysteine thiol of peptide-e in the absence
of 2-4Zn(II) was determined to be 8.48, which was lower by approximately 0.4 pH unit than that of peptide-
d (pKa = 8.89). Another strategy of lowering the pKa value of cysteine thiol was the introduction of a posi-
tively charged amino acid, which can electrostatically stabilize an adjacent cysteine residue (Lutolf et al.,
2001). We thus designed peptide-g and peptide-h, which possess two Lys or Arg residues at the N termini,
respectively. The pKa values of these peptides (pKa = 8.04 and 8.02, respectively) were apparently lower
than that of peptide-e (pKa = 8.48), indicative of electrostatic stabilization of the thiolate anion by the258 iScience 22, 256–268, December 20, 2019
2-4Zn(II) () 2-4Zn(II) (+)
pKa k (3 10
2, s1)a pKa k (3 10
2, s1)a
peptide-d: Ac-YGCAAADAAADAAADAA
AD-NH2
8.89 0.66 7.94 1.51
peptide-e: Ac-GGCPYADAAADAAADAA
AD-NH2
8.48 2.00 7.46 5.11
peptide-f: Ac-YGCPAADAAADAAADAA
AD-NH2
8.93 0.37 7.80 1.24
peptide-g: Ac-KKCPYSDAAADAAADAA
AD-NH2
8.04 2.51 7.13 7.60
peptide-h: Ac-RRCPYSDAAADAAADAA
AD-NH2
8.02 2.92 7.18 6.72
peptide-i: Ac-YGCAAAAAADDDDGDD
DD-NH2
8.96 1.17 8.22 1.78
Table 1. Summary of the pKa Values of the Cysteine Residue in the Peptides, and the First-Order Reaction Rate Constants (k, s
1) with mCBI in the
Presence or Absence of 2-4Zn(II)
aMeasurement conditions: 50 mM HEPES, 100 mM NaCl, pH 7.2, 37C.positively charged amino acid residues. Most interestingly, the pKa values of all peptides largely decreased
by approximately 1 pH unit in the presence of 2-4Zn(II). The lowest pKa value (pKa = 7.13) was observed in
the binding complex of peptide-g with 2-4Zn(II). Conversely, the previously developed peptide-i (D4-tag)
(Nonaka et al., 2010) showed the highest pKa value (pKa = 8.22) among the peptides.
The first-order reaction rate constant (k, s1) of the peptides with mCBI under neutral aqueous solution
(50 mM HEPES, 100 mM NaCl, pH 7.2, 37C) is summarized in Table 1. Notably, the reaction rate order
correlated well with that of the pKa value of the cysteine thiol. That is, a peptide with a low pKa exhibited
high reactivity, suggesting that the thiolate anion served as the main reactive species in the nucleophilic
reaction with mCBI. Furthermore, 2-4Zn(II) accelerated the reaction of all a-helical peptides (peptides-
d–h) with mCBI, consistent with their low pKa values in the binding complex. The most reactive peptide
was peptide-g: its reaction rate in the presence of 2-4Zn(II) (k = 7.60 3 102 s1) was over ten times higher
than that of the initially designed peptide-d in the absence of 2-4Zn(II) (k = 0.66 3 102 s1). These obser-
vations demonstrated the validity of our strategy to gain a highly reactive peptide tag by lowering the pKa
value of the cysteine.
Tuning of Probe Reactivity for Enhanced Labeling Selectivity
To reduce the non-specific labeling activity of the Zn(II) complex, we next tuned its reactivity. Michael
acceptor is an important class of reactive group for cysteine thiol and has been widely used for protein
modification with synthetic probes and covalent drugs (Singh et al., 2010). Considering the broad tunability
of its reactivity (Flanagan et al., 2014), we prepared the monomer-type zinc complexes 3-2Zn(II) to 5-2Zn(II)
bearing a different Michael acceptor group (Figure S3) and evaluated their reactivity with peptide-g by us-
ing mCBI. The kinetic analysis revealed that the reactivity of 5-2Zn(II) (t1/2 = 3.98 h) bearing a g-dimethyla-
minocrotonate (DMAC) (Wissner et al., 2003) as Michael acceptor group was substantially lower than that of
a-chloroacetamide 6-2Zn(II) (t1/2 = 0.20 h). These data suggested the potential utility of DMAC as a reactive
group of the labeling probe with a moderate reactivity. The other Michael acceptor-type probes 3-2Zn(II)
and 4-2Zn(II), which bears a cinnamide and crotonamide, respectively, showed the low reactivity with pep-
tide-g (t1/2 > 24 h).
We next evaluated the reactivity of dimer-type zinc complexes 7-4Zn(II) to 9-4Zn(II) bearing a DMAC group
(Table 2). Their reactivity was evaluated with peptide-g to peptide-i, which possessed the different number
of alanine residue(s) for optimization of spatial orientation between the cysteine residue and the bound
Zn(II) complex. Interestingly, the reactivity was greatly affected by the structure of the Zn(II) complex: the
reaction rate of 9-4Zn(II), possessing a rigid L-proline linker, with peptide-g (t1/2 = 0.74 h) was higher
than that of 7-4Zn(II) (t1/2 = 3.3 h). In contrast, 8-4Zn(II) possessing an ethylene glycol linker exhibited aiScience 22, 256–268, December 20, 2019 259
t1/2 (h)
7-4Zn(II) 8-4Zn(II) 9-4Zn(II)
peptide-g: Ac-KKCPYSDAAADAAADA
AAD-NH2
3.30 13.9 0.74
peptide-j: Ac-KKCPYSADAAADAAADA
AAD-NH2
2.69 16.0 0.24
peptide-k: Ac-KKCPYSAADAAADAAADA
AAD-NH2
1.96 9.84 0.22
peptide-i: Ac-YGCAAAAAADDDDGD
DDD-NH2
6.78 –a 2.84
Table 2. Summary of the Reaction Half-Time (t1/2, h) of the Zinc Complexes with the Peptides
Measurement conditions: 50 mM HEPES, 100 mM NaCl, pH 7.2, 37C.
aNot determined.much lower reactivity (t1/2 = 13.9 h). The reactivity was also influenced by the number of inserted alanine(s)
in the peptide tag: peptide-k, which possessed two additional alanine residues, showed a higher reactivity
(t1/2 = 0.22 h) for 9-4Zn(II) compared with peptide-g (t1/2 = 0.74 h). Consequently, 9-4Zn(II) and peptide-k
were identified as the optimized tag-probe pair with the highest reactivity. We confirmed that the pKa
values of peptides with inserted alanine(s) (peptide-j and -k) in a binding complex with 2-4Zn(II) were
7.08 and 7.14, respectively, which were comparable with that of peptide-g (pKa = 7.13) (Figure S4). Overall,
the reactivity of the optimized tag-probe pair (i.e., 9-4Zn(II) and peptide-k, t1/2 = 0.22 h) was approximately
30-fold higher than that of the previously developed D4-tag peptide-i with the structurally unoptimized
7-4Zn(II) (t1/2 = 6.78 h, Table 2).
Fluorescence Labeling of HelixD2-Tag-Fused Protein
The optimized tag-probe pair was used for fluorescence labeling of tag-fused proteins. We first employed
maltose-binding protein (MBP) tagged with the 21-amino acid peptide-k, named helixD2-tag (KKCPYSAA
DAAADAAADAAAD). The labeling reaction of helixD2-MBP was conducted with the fluorescent zinc com-
plex 10-4Zn(II) bearing an Oregon green 488 under aqueous buffer conditions (50 mM HEPES, 100 mM
NaCl, pH 7.2) (Figure 3A). In-gel fluorescent analysis revealed that the labeling reaction proceeded in a
time-dependent manner (Figures 3B and 3C). The half reaction time (t1/2) was determined to be 0.28 h
by pseudo-first-order kinetic analysis, which was comparable with that of the reaction between peptide-k
and 9-4Zn(II) (t1/2 = 0.22 h, Table 2). The second-order reaction rate constant of the labeling reaction of
helixD2-MBPwith 9-4Zn(II) was also determined to be 9.43 102M1 s1 by the detailed kinetic analysis (Fig-
ure S5). A control labeling reaction was conducted using MBP tagged with the cysteine-containing histi-
dine-rich peptide (CH6 tag; CHHHHHH). As shown in Figure 3B, no labeling adduct was detectable
with CH6-MBP, consistent with the weak binding affinity of the zinc complex and hexahistidine peptide
(Ka < 10
3 M1) (Uchinomiya et al., 2014).
We next applied the tag-probe pair to the covalent labeling of GPCR protein on the cell surface. In the
experiment, bradykinin receptor type2 (B2R) was tagged with a helixD2-tag (located at the extracellular260 iScience 22, 256–268, December 20, 2019
Figure 3. Fluorescence Labeling of helixD2-Tag-Fused Protein
(A) Structures of the fluorescent Zn(II)-DpaTyr probes.
(B) In-gel fluorescence (FL) and Coomassie Brilliant Blue (CBB) analysis of covalent labeling of MBP tagged with a helixD2-tag (upper panel) or CH6 tag
(lower panel) by 10-4Zn(II). Labeling conditions: [tag-MBP] = 1 mM, [10-4Zn(II)] = 10 mM, 50 mM HEPES, 100 mM NaCl, 20 mM TCEP, pH 7.2, 37C.
(C) Time-trace plot of the fluorescence band intensity of the MBP labeled with 10-4Zn(II) (mean G SD of triplicate experiment).
(D and E) Fluorescence imaging of HEK293 cells expressing B2R fused with helixD2-tag (D) or CH6 tag (E) upon labeling with 10-4Zn(II). Labeling conditions:
[10-4Zn(II)] = 4 mM, HEPES-buffered saline, pH 7.4, 37C, 30 min.
(F and G) (F) Fluorescence images of non-specific labeling on surface of HEK293 cells without expression of the tag-fused B2R. Labeling conditions:
[10-4Zn(II) or 11-4Zn(II)] = 4 mM, HEPES-buffered saline, 20 mM TCEP, pH 7.4, 37C, 30 min (G) Time-trace plot of the fluorescence intensity on the surface of
HEK293 cells without expression of the tag-fused B2R (n = 10, mean G SD).N-terminal region of B2R) and transiently expressed in HEK293 cells. When the cells were pre-treated with
tris(2-carboxyethyl)phosphine (TCEP) to activate the cysteine residue of the tag, and then incubated with
4 mM of 10-4Zn(II) for 30 min at 37C, the bright fluorescence signal was observed on the cell surface (Fig-
ure 3D). The obtained fluorescence image overlapped well with that of the fluorescent B2R antagonist
peptide, indicative of selective covalent labeling of the tag-fused B2R by 10-4Zn(II). The fluorescence of
10-4Zn(II) was not observed on the cell surface when the labeling reaction was conducted in the presence
of 1 mM inorganic pyrophosphate (PPi), a strong binder to the zinc complex (Figure S6). Similarly, the la-
beling of HEK293 cells expressing B2R tagged with CH6 did not show any fluorescence on the cell surface
(Figure 3E). These data suggest that the selective binding between the helixD2-tag and 10-4Zn(II) is essen-
tial for the efficient covalent labeling of B2R.
To evaluate the non-specific labeling activity of the probes on the cell surface, HEK293 cells that did not
express B2R were treated with 10-4Zn(II) or a-chloroacetamide probe 11-4Zn(II) (4 mM, 37C), and the fluo-
rescence of the cell surface was quantified by confocal microscopy with a high laser power after formalde-
hyde fixation (Figures 3F and 3G). The result revealed that the fluorescence of 10-4Zn(II) associated with
non-specific reaction was apparently weaker than that of the highly reactive 11-4Zn(II). Furthermore,
11-4Zn(II) induced a noticeable time-dependent increase of the fluorescence signal on the cell surface.
These data clearly indicated that non-specific labeling activity of 10-4Zn(II) was significantly lower than
that of 11-4Zn(II). The fluorescence of 11-4Zn(II) substantially decreased without the reductive treatment
with TCEP, implying that cysteine residue of membrane proteins was the major non-specific labeling
site. The weak non-specific reactivity of 10-4Zn(II) was also confirmed by the labeling experiment of the
helixD2-MBP under E. coli lysate conditions (Figure S7). In-gel fluorescence analysis of the lysate sampleiScience 22, 256–268, December 20, 2019 261
Figure 4. EM Detection of helixD2-Tag-Fused B2R Protein on Freeze-Fracture Replicas
(A) Schematic illustration of labeling states of a complementary replica pair.
(B and C) EM images of the complementary replicas showing E-face (B) and P-face (C) from the samemembrane. Scale bars, 1 mm. (Insets) Magnified images
of the area framed in the main pictures. Arrowheads indicate 5-nm gold particles. Scale bars, 100 nm.
(D) Comparison of the labeling density of 12-4Zn(II) on the E- and P-face images, respectively (****p < 0.001, Mann-Whitney U test; E-face, n = 11; P-face,
n = 9, mean G SE).
(E) Comparison of the labeling density of anti-GFP antibody on the E- and P-face images, respectively (****p < 0.001, Mann-Whitney U test; E-face, n = 7;
P-face, n = 15, mean G SE).revealed that the band intensities of proteins non-specifically labeled by 10-4Zn(II) were significantly lower
than those labelled by 11-4Zn(II).
EMDetection of Tag-Fused Protein Using Biotin and Nanogold-Conjugated Probes in Freeze-
Fracture Replica
We applied chemical labeling to EM detection in combination with sodium dodecyl sulfate (SDS)-digested
freeze-fracture replica labeling (SDS-FRL) technique (Fujimoto, 1995). This technique is widely used to
detect the two-dimensional distribution of membrane proteins on protoplasmic (P-) and exoplasmic
(E) leaflet of lipid bilayer in freeze-fracture replicas (Meier and Beckmann, 2018). In the current study,
we first used the biotin probe 12-4Zn(II) to detect helixD2-B2R-EGFP, which harbored an extracellular
N-terminal helixD2-tag and an intracellular C-terminal enhanced green fluorescent protein (EGFP) (Fig-
ure 4A). The labeling specificity of 12-4Zn(II) toward helixD2-B2R-EGFP was confirmed by fluorescence
imaging using Alexa Fluoro 633-conjugated streptavidin (SA) (Figure S8). For EM detection, helixD2-
B2R-EGFP, expressed on the surface of live HEK293 cells, was labeled with 12-4Zn(II) followed by secondary
labeling with SA-conjugated 1.4-nm gold particle. After fixation with paraformaldehyde, a complementary262 iScience 22, 256–268, December 20, 2019
Figure 5. EM Detection of helixD2-Tag-Fused B2R Protein on HEK Cells Using the Probe Conjugated with a
1.4-nm Gold Particle
(A) Schematic illustration of labeling states of replicas.
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Figure 5. Continued
(B–D) Dark-field scanning transmission electron microscopy images of E-face replicas made from transfected (B and C) or
non-transfected (D) HEK cells labeled with 13-4Zn(II) before aldehyde fixation. (C) and the inset on (D) are magnified
images of the area framed in (B) and (D), respectively. White arrowheads indicate B2R clusters labeled with 13-4Zn(II).
Scale bar: 200 nm in (B) and the main picture of (D) and 50 nm in (C) and the inset on (D).
(E and F) Dark-field images of replicas made from transfected HEK cells labeled with 13-4Zn(II) after aldehyde fixation. (F)
A magnified image of the area framed in (E). Scale bar: 200 nm in (E) and 50 nm in (F).
(G) Bright-field TEM image of E-face replica labeled with anti-FLAG antibody combined with 5-nm gold-particle-
conjugated secondary antibody. Black arrowheads indicate B2R clusters labeled with 5-nm gold particles. Scale bar,
200 nm.
(H) Comparison of the specific and background labeling density with 13-4Zn(II) and anti-FLAG antibody. ‘‘13-4Zn(II)’’ and
‘‘13-4Zn(II), fixed cells’’ indicate results from HEK cells labeled before and after aldehyde fixation, respectively (13-4Zn(II),
****p < 0.001, Mann-Whitney U test; specific labeling, n = 9 cells; background labeling, n = 13 cells; mean G SE, anti-
FLAG, ***p < 0.005, Mann-Whitney U test; specific labeling, n = 7 cells; background labeling, n = 7 cells; meanG SE, 13-
4Zn(II), fixed cells, ****p < 0.001, Mann-Whitney U test; specific labeling, n = 11 cells; background labeling, n = 15 cells;
mean G SE).
(I) Distribution histograms of nearest neighbor distance (NND) of gold particles observed on replicas labeled with 13-
Zn(II) (upper, n = 1748 particles) and anti-FLAG antibody (bottom, n = 998 particles). Fitted lines show Gaussian
distribution fitting for the peaks.
(J) Comparison of the number of particles per B2R cluster labeled with 13-4Zn(II) and anti-FLAG antibody. ‘‘Max 12 nm’’
and ‘‘Max 42 nm’’ mean the maximum NND of gold particles used for the definition of clusters labeled with 13-4Zn(II) and
anti-FLAG antibody (13-4Zn(II) Max 12 nm; n = 10 cells, 13-4Zn(II) Max 42 nm, n = 10 cells; anti-FLAGMax 42 nm, n = 7 cells,
mean G SE, **p < 0.01, Mann-Whitney U test).
(K) Comparison of the B2R cluster area evaluated by chemical labeling with 13-4Zn(II) and immunolabeling with anti-FLAG
antibody (13-4Zn(II) Max 12 nm; n = 10 cells; 13-4Zn(II) Max 42 nm, n = 10 cells; anti-FLAG 42 nm, n = 7 cells; meanG SE,
n.s. p > 0.05, Mann-Whitney U test).pair of P- and E-face freeze-fracture replica was prepared using the double replica method (Figure 4A). One
replica of the pair underwent silver enhancement to increase the visibility of 1.4-nm gold particles labeled
by the chemical labeling on the E-face. In another replica of the pair, EGFP was immunolabeled with 5-nm
gold particles to detect helixD2-B2R-EGFP on the P-face. EM analysis revealed selective labeling of the
helixD2-tag by the probe on the E-face (Figures 4B and 4D) and vice versa, selective labeling of EGFP
on the corresponding P-face (Figures 4C and 4E). These observations are consistent with the extracellular
location of the helixD2-tag and the intracellular location of EGFP.
Although the density of gold particles looked higher for EGFP than helixD2-tag, it is necessary to visualize
each of them on the E-face to compare the labeling efficiency, because the allocation of helixD2-B2R-EGFP
to the P-face and E-face can be different. In addition, binding of the biotin probe 12-4Zn(II) and SA-conju-
gated particle can be disrupted by SDS treatment at 60C reducing the labeling efficiency. Thus, we next
used 13-4Zn(II), which possesses a directly conjugated 1.4-nm nanogold particle to label helixD2-B2R-
EGFP, and anti-FLAG antibody to label FLAG tag, which was inserted just next to the helixD2 tag in the
extracellular domain of B2R (Figure 5A). Probe 13-4Zn(II) was obtained by conjugation reaction of the
amine probe 14-4Zn(II) with mono-sulfo-N-hydroxy-succinimide nanogold particles in HEPES buffer
(pH 8.0), which was followed by dialysis to remove the excess of 14-4Zn(II). The labeling reaction of
13-4Zn(II) was conducted for an extended time (2 h, 37C) to fully label helixD2-B2R-EGFP expressed on
HEK293 cells. To facilitate searching for E-face labeled with 1.4-nm gold particles by 200kV scanning trans-
mission electron microscope (dark field mode), GluA2 subunit of a-amino-3-hydroxy-5-methyl-4-isoxazole-
propionic acid-type glutamate receptor was co-expressed with helixD2-B2R-EGFP in HEK cells and labeled
with 10-nm gold particles by an antibody for an extracellular epitope of GluA2 combined with anti-rabbit
10-nm gold particle-conjugated secondary antibody (Figure S9). On GluA2-labeled E-face, we found
numerous 1.4-nm gold particles, often making high-density clusters of particles (Figures 5B and 5C). The
specificity of the labeling was confirmed using HEK cells transfected with GluA2 but not with helixD2-
B2R-EGFP (Figure 5D). The density of background labeling (5.9 particles/mm2) was 1.7% of the specific la-
beling (353 particles/mm2) (Figure 5H). In the immunogold labeling, the specific labeling by anti-FLAG tag
antibody was observed on the E-face with 5-nm particles (125 particles/mm2, n = 7 cells, Figure 5H), also
showing clusters of particles (arrowheads in Figure 5G). The average density of B2R labeled with
13-4Zn(II) was 2.8 times higher than that with anti-FLAG antibody (Figure 5H, p < 0.05).
To compare the clusters of particles obtained with the chemical labeling and anti-FLAG immunolabeling,
we first examined nearest neighbor distance (NND) distributions of particles and found sharper peak at264 iScience 22, 256–268, December 20, 2019
smaller NND for the chemical labeling (8.6 G 10.8 nm, mean G SD, n = 1748 particles) than immunolab-
eling (47.4 G 56.1 nm, mean G SD, n = 998 particles, p < 0.001, Mann-Whitney U test) (Figure 5I). For
defining the clusters, we fitted these peaks with Gaussian distribution and used mean + 2 SD as
maximum distances allowed and three particles per cluster as a minimum number of particles per cluster
(Miki et al., 2017). In case we use definition of clusters with different mean + 2 SD values for chemical
labeling (12 nm) and immunolabeling (42 nm), the numbers of particles per cluster were similar (Figure 5J)
but the cluster area was much smaller for chemical labeling (70 nm2) than for immunolabeling (950 nm2,
Figure 5K), indicating that the clusters detected by chemical labeling represent subclusters consisting
single clusters detected by immunolabeling. In case we use the same definition of clusters obtained
by immunolabeling for both (42 nm as a maximum distance allowed), the cluster areas became similar
and the number of particles per cluster was twice higher for chemical labeling than for immunolabeling
(9.4G 1.4 particles, n = 10 cells for chemical labeling, 4.5G 0.3 particles, n = 7 cells for immunolabeling,
mean G SE, p < 0.01, Mann-Whitney U test, Figures 5J and 5K). Altogether, these results indicate higher
labeling efficiency and detectability of high-density nanoclusters of proteins for chemical labeling with
the probe directly conjugated with 1.4-nm nanogold particle than the immunolabeling with 5-nm
gold-particle-conjugated secondary antibody.
In typical SDS-FRL experiment, biological samples, such as sliced tissue, are initially fixed with aldehyde to
maintain protein location by physical stabilization (Masugi-Tokita and Shigemoto, 2007). Therefore, we
next applied the chemical labeling to the fixed cell samples. HEK293 cells expressing helixD2-B2R-EGFP
were first fixed with 2% paraformaldehyde and then labeled with 13-4Zn(II). We found specific labeling
for helixD2-B2R-EGFP with the fixed cells comparable with that obtained with living cells (Figures 5E, 5F,
and 5H). This was indicative of the compatibility of the developed chemical labeling with aldehyde fixation.
Since the majority of the existing enzyme-mediated and ligand-directed protein labeling methods (Walper
et al., 2017; Matsuo and Hamachi, 2017) are difficult to apply to denatured proteins by fixation, these results
demonstrated the high utility of the chemical labeling method for SDS-FRL using fixed biological samples.
EM Detection of Tag-Fused Protein Using Nanogold-Conjugated Probes in Ultrathin Section
To further confirm higher resolution of the chemical labeling using 13-4Zn(II), we performed EM analysis
of ultrathin sections of resin-embedded HEK293 cells. We compared the distances from the silver-inten-
sified 1.4-nm gold particles to cell membrane between the samples labeled by 13-4Zn(II) and those
labeled by anti-FLAG antibody combined with 1.4-nm gold-particle-conjugated secondary antibody (Fig-
ures 6A and 6C). The background density of particles examined in non-transfected cells was 0.8% and
0.6% of the specific labeling by 13-4Zn(II) and anti-FLAG antibody, respectively. The silver-intensified
gold particles appeared to be mostly attached to the cell membrane in the chemical labeling (Figure 6B),
whereas those in the FLAG immunolabeling showed apparent gaps between the particles and the cell
membrane (Figure 6D). Considering that silver intensification may occur in a non-isotropic/concentric
manner around 1.4-nm gold particles, we used minimum time (3–6 min) for silver intensification and
examined the correlation of the size of silver-intensified particles and the distance between the center
of silver-intensified particles and the midpoint of lipid bilayer (Figure 6E). We found a significant positive
correlation for both chemical labeling (rs = 0.24, p < 0.01, n = 147 particles) and immunolabeling (rs =
0.26, p < 0.01, n = 228 particles). By extrapolating linear fits, estimated distances of non-intensified
1.4-nm particles were calculated to be 5.4 nm and 9.9 nm for chemical labeling and immunolabeling,
respectively. Since the half thickness of lipid bilayer was estimated to be 4 nm by EM analysis (Robertson,
1958), the distance of 1.4-nm gold particles from the cell surface was deduced to be 1.4 and 5.9 nm for
the chemical labeling and immunolabeling, respectively (Figure 6E). Although direct comparison of the
distances from these labels to the respective tags is not possible because the exact tag positions are
unknown, the variance of the measured distances is significantly smaller for 13-4Zn(II) than for anti-
FLAG antibody (F227, 146 = 2.0, p < 0.001), indicating higher resolution of the chemical labeling method
than the immunolabeling method (Figure 6F).
Conclusion
In summary, we have achieved EM detection of GPCR by chemical labeling using a reactive peptide tag-
probe pair. Rational design of the highly reactive a-helical peptide tag and the fine-tuning of probe reac-
tivity enabled the specific cysteine conjugation of the tag-fused B2R protein on cell surface. EM detection
using the tag-probe pair was successfully applied to determine the localization of B2R receptor on cell sur-
face with a high labeling specificity. Furthermore, the probe directly conjugated with a 1.4-nm gold particleiScience 22, 256–268, December 20, 2019 265
Figure 6. Comparison of Resolution between Chemical Labeling and Immunolabeling Methods
(A and C) Schematic illustration of labeling states of the tagged-B2R on HEK cells labeled with 13-4Zn(II) (A) and anti-FLAG antibody combined with 1.4-nm
gold-particle-conjugated secondary antibody (C).
(B and D) EM images of ultrathin sections prepared from HEK cells labeled with 13-4Zn(II) (B) and anti-FLAG antibody (D), respectively. Gold particles were
intensified by silver enhancement for 3–6 min. Distances between the particle center and the middle of the cell membrane were measured in sections tilted
to obtain perpendicular views to the plasma membrane. Scale bars, 20 nm (left) and 10 nm (right).
(E) Correlation of the intensified particle size and distance between particle centers and the middle of the cell membrane (orange dots, 13-4Zn(II); blue dots,
anti-FLAG antibody). Significant positive correlation was detected for both (correlation coefficient = 0.24, p < 0.01, n = 147 for 13-4Zn(II); correlation
coefficient = 0.26, p < 0.01, n = 228 for anti-FLAG antibody, Pearson correlation analysis). The distances for non-intensified 1.4-nm particles were deduced
from linear fits extrapolated (broken orange and blue lines) to 1.4 nm (red dotted line).
(F) Schematic illustration of positions of non-intensified 1.4-nm particles estimated by the two labeling methods in (E). The gradient circle indicates the
deviation of the position.enabled the detection of the membrane proteins with a few times higher labeling efficiency and signifi-
cantly higher spatial resolution than that of the antibody-mediated labeling, revealing high-density nano-
clusters of proteins. EM detectionmethods for in-cell proteins using genetically encoded peroxidases have
been developed in recent years (Shu et al., 2011; Martell et al., 2012; Hainfeld and Powell, 2000). Despite
their usefulness, these methods are hardly applicable to single-protein detection since they have been
devised for EM contrast imaging based on OsO4 staining in combination with oxidative diaminobenzidine
(DAB) polymerization. To the best of our knowledge, the research presented herein is the first example of
high-resolution single-protein detection by EM utilizing a chemical labeling. The use of our labeling
method is currently limited to cell surface proteins. Nevertheless, this method can be widely used for
EM analysis of membrane proteins on replicas in combination with SDS-FRL. We envision further applica-
tion of the chemical labeling approach to reveal subunit composition of single-protein complexes on cell
surface in combination with other tag-probe pairs (Uchinomiya et al., 2013).Limitations of the Study
In our study, we demonstrate higher efficiency and resolution of the newly developed chemical labeling
method compared with the common immunolabeling methods at the EM level using HEK cells expressing
tagged B2R. Accurate evaluation of labeling resolution, however, requires understanding of the exact mo-
lecular structure of the tagged receptor. Since background and labeling conditions can be different be-
tween cell culture and various tissue environments, usefulness of the reported reactive peptide tag-probe
pair needs further verification in more complex sample preparations.266 iScience 22, 256–268, December 20, 2019
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
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Figure S1. CD spectral change of peptide-a upon the addition of 2-4Zn(II), Related to Figure 2. 
Measurement conditions: [peptide-a] = 50 µM, [2-4Zn(II)]  = 0, 10, 20, 30, 40, and 50 µM, 10 
mM borate buffer, pH 8.0, 25 °C. 
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Figure S2. ITC titration curve (upper) and processed data (lower) of 1-2Zn(II) with peptide-c 
(Ac-DAAAD-NH2), Related to Figure 2. [1-2Zn(II)] = 50 µM, [peptide-c] = 6 mM (5 µL × 48 
injections), 50 mM HEPES, 100 mM NaCl, pH 7.2, 25°C. 
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Figure S3. Evaluation of the reactivity of the zinc complexes with peptide-g, Related to Table 2. 
(a) Structures of the zinc complexes and their reaction half-time (t1/2, h) with peptide-g. (b) 
Fluorescence intensity change of the solution containing peptide-g and 5-2Zn(II) upon treatment 
with mCBI (reaction time: 0, 1, 3, 6, 9, and 12 h, from the upper to lower trace). The dashed line 
indicates the fluorescence of mCBI in the absence of peptide-g. Measurement conditions: 
[peptide-g] = 50 µM, [probe] = 100 µM, 50 mM HEPES, 100 mM NaCl, pH 7.2, 37 °C. (c) Plot 
of fluorescence intensity change for the selected reaction pairs: peptide-g and 7-4Zn(II) (), 
peptide-g and 8-4Zn(II) (q), peptide-k and 9-4Zn(II) (¢), and peptide-i and 7-4Zn(II) (p). 
Measurement conditions: [peptide] = 50 µM, [probe] = 60 µM, 50 mM HEPES, 100 mM NaCl, 
pH 7.2, 37 °C. 
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Figure S4. pH-dependent reaction rate profiles of peptide-j (a) and peptide-k (b) with mCBI in 
the presence and absence of 2-4Zn(II), Related to Table 2. pKa values were evaluated by applying 
non-linear curve fitting analysis according to Henderson-Hasselbalch equation.  
 
 
 
 
 
 
Figure S5. Second-order rate analysis of the labeling reaction of helixD2-tag fused MBP protein 
with 10-4Zn(II), Related to Figure 3. The data was analyzed by double reciprocal Lineweaver-
Burk plot between the probe concentration (1/[10-4Zn(II)]) and initial reaction rate (1/Vo). 
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Figure S6. Fluorescence imaging of HEK293 cells expressing helixD2-tag fused B2R upon the 
labeling with 10-4Zn(II) in the presence of 1 mM pyrophosphate (PPi), Related to Figure 3. 
Labeling conditions: [10-4Zn(II)] = 4 µM, HEPES-buffered saline, pH 7.4, 37 °C, 30 min. 
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Figure S7. Evaluation of non-specific labeling activity of the probes in E.coli lysate, Related to 
Figure 3. (a) In-gel fluorescence analysis of helixD2-MBP labeling by 10-4Zn(II) and 11-4Zn(I) 
in the presence of E.coli lysate. (b) CBB image of the gel shown in (a). (c) time-trace plot of the 
band intensity of helixD2-MBP labeled by 10-4Zn(II). (d) Comparison of band intensity of 
helixD2-MBP labeled by 10-4Zn(II) or 11-4Zn(II) at 3 hr. (e) Comparison of relative band 
intensity ratio of helixD2-MBP against whole proteins labeled by 10-4Zn(II) or 11-4Zn(II). Note 
that the relative band intensity ratio of 10-4Zn(II) is significantly higher than that of 11-4Zn(II) 
as shown in (e), while the band intensity of helixD2-MBP labeled by 10-4Zn(II) was not greatly 
different from that by 11-4Zn(II) as shown in (d).    
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Figure S8. Fluorescence imaging of helixD2-tag fused B2R upon the labeling with 12-4Zn(II), 
Related to Figure 4. The labeling reaction was conducted by the same procedure as described for 
10-4Zn(II). After the labeling, the cells were treated with Alexa Fluoro 633-conjugated 
streptavidin (5 µg/mL in PBS) and subjected to fluorescence imaging. 
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Figure S9. Characterization of rabbit polyclonal antibody for GluA2 AMPA receptor subunit 
raised against a synthetic peptide (CERDKVNDIVDQVITIGKH), Related to Figure 5. (a) 
Western-blotting analysis to characterize specificity of the anti-GluA2 antibody. The antibody 
recognizes a broad band (100-120 kDa) on immunoblots of rat brain LP1 (crude synaptic plasma 
membrane) and a weak band on LP2 (synaptic vesicle). Subcellular fractionation was performed 
as described (Yamamori et al., 2011). (b and c) EM images of replicas prepared from GluA2-
transfected (b) and non-transfected (c) HEK cells labeled with the anti-GluA2 antibody followed 
by 10 nm gold-conjugated secondary antibody. Scale bars, 200 nm. 
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Transparent Methods 
 
Circular Dichroism (CD) Measurement. Aqueous solution of the zinc complex was added to 
a solution of the peptide (50 µM) in 10 mM borate buffer (pH 8.0). CD spectrum was measured 
at rt in a quartz cell (0.1 cm path length) using JASCO J-720W spectropolarimeter. The data of 
each sample was collected by 5 scans (scan range; 350 ~ 190 nm, scan speed; 50 nm•min-1) and 
averaged to give CD spectrum. 
 
Isothermal Titration Calorimetry (ITC) Measurement. ITC titration was performed with 
isothermal titration calorimeter (Malvern) at 298 K. Solution of peptide-c (6.0 mM) in buffer 
solution (50 mM HEPES, 100 mM NaCl, pH 7.2) was injected stepwise (5 µL x 48 times) to 
solution of 1-2Zn(II) (50 µM) in the same solvent system. The measured heat flow was recorded 
as function of time and converted into enthalpies (DH) by integration of the appropriate reaction 
peaks. Dilution effects were corrected by subtracting feat flow of blank experiment upon injection 
of the HEPES buffer under identical experimental conditions. The binding parameters (Kapp, DH, 
DS, n) were evaluated by applying one site model using the software Origin (Malvern). 
 
Evaluation of Binding Constant. In a quartz cell, peptide-b (0.05 µM, final concentration) 
dissolved in 3 mL buffer (50 mM HEPES 100 mM NaCl, pH 7.2) was titrated with a freshly 
prepared aqueous solution of 2-4Zn(II) using a micro syringe at 25 °C. The fluorescence spectrum 
was measured (lex = 410 nm) using Perkin-Elmer LS55 spectrometer at each titration point. The 
change of the fluorescence intensity at 448 nm was analyzed by nonlinear least-square curve-
fitting method to yield the apparent binding constant (Kapp, M-1). 
 
Kinetic Analysis of Nucleophilic Reaction of Peptide with mCBI. 10 µL of stock solution of 
mCBI (10 mM in DMSO) was added to a solution of peptide (4 µM) in 0.8 mL of buffer (50 mM 
HEPES 100 mM NaCl, pH 7.2, degassed under reduced pressure and charged with nitrogen before 
use) in the presence or absence of 2-4Zn(II) (14 µM). The fluorescence emission at 486 nm was 
continuously monitored by Perkin-Elmer LS55 spectrometer ((lex = 396 nm) at 37 °C. The 
emission change was analyzed by nonlinear least-square curve-fitting method to yield the first-
order reaction constant (k, sec-1). For evaluation of pKa value of the cysteine residue, initial 
reaction rate of fluorescence change (Vo, DF, min-1) were measured under the different pH 
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conditions in universal pH buffer (5 mM CHES-5 mM HEPES-5 mM MES, degassed under 
reduced pressure and charged with nitrogen before use) at 37 °C. The change of the initial rate 
over the pH range was analyzed by nonlinear curve-fitting method according to Henderson-
Hasselbalch equation to yield pKa value. 
 
Kinetic Analysis of Cysteine Conjugation of Peptide with Zinc Complex. Peptide (50 µM) 
and zinc complex (60 µM) was dissolved in 200  L of buffer solution (50 mM HEPES 100 mM 
NaCl, pH 7.2, degassed under reduced pressure and charged with nitrogen before use) and 
incubated at 37 °C in a plastic tube. Aliquot of the solution (20 µL) was sampled at appropriate 
times and mixed with 6 µL of inorganic pyrophosphate solution (10 mM in water) to quench the 
reaction followed by being  kept at -20 °C. The thawed samples were mixed with 4 µL of mCBI 
(5 mM in DMSO) and incubated at 37 °C for 1 h in a dark. The solution (18µL) was diluted with 
a 582 µL of buffer solution (50 mM HEPES 100 mM NaCl, pH 7.2), and the fluorescence was 
measured (lex = 396 nm) in a quartz cell using Perkin-Elmer LS55 spectrometer. The fluorescence 
change (lem = 486 nm) was analyzed by nonlinear least-square curve-fitting method according to 
second-order equation to yield half-reaction time (t1/2, h).  
 
Fluorescence Detection of Covalent Labeling of Tag-fused MBP.  A solution of helixD2-tag-
fused MBP (1 µM) or CH6 tag-fused MBP (1 µM) in 50 mM HEPES, 100 mM NaCl, 20 µM 
TCEP, pH 7.2 (degassed under reduced pressure and charged with nitrogen before use) was mixed 
with 10-4Zn(II) (10 µM, final concentration), and the mixture was incubated in a plastic tube at 
37 °C. Aliquot of the solution (8 µL) was sampled at the appropriate times and mixed with 2 µL 
inorganic pyrophosphate solution (10 mM in water) followed by being kept at -20 °C. After 
thawing, the samples were mixed with 5x sampling buﬀer and heated at 95 °C for 2 min followed 
by being applied to SDS-PAGE. In-gel fluorescence and CBB analyses were performed with 
LAS-4000 lumino image analyzer (FUJIFILM) by EPI (460 nm excitation, Y515Di filter) and 
DIA-W mode, respectively. 
 
Cell Culture and B2R Expression in HEK293 Cells. HEK293 cells were cultured in high 
glucose DMEM supplemented with 10% fetal bovine serum (FBS), penicillin (100 units/mL), 
streptomycin (100 µg/mL) and amphotericin B (250 ng/mL). Cells were maintained at 37 ºC in 
humidified atmosphere of 5% CO2 in air. Subculture was performed every 3-4 days from 
subconfluent (< 80%) cultures using trypsin-EDTA solution. Transfection of the expression 
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vector for B2R was carried out in a 35 mm glass-bottomed dish (Iwaki) using Lipofectamine LTX 
(Invitrogen) according to the general procedure. The cells were subjected to labeling experiment 
after 48 h of the transfection. 
 
Fluorescence Imaging of Tag-fused B2R. In a glass bottom dish, HEK293 cells (~ 1 x 106) 
transiently expressing helixD2-tag fused B2R or CH6 tag-fused B2R were incubated in non-
serum Dulbecco's modified Eagle medium (DMEM) containing 2-deoxy-D-glucose (10mM) and 
sodium azide (6 mM) for 30 min at 37 °C in CO2 incubator. After removal of DMEM, cells were 
treated with TCEP (1 mM) for 10 min at rt in 1 mL HEPES-buffered saline (HBS, containing 107 
mM NaCl, 6 mM KCl, 1.2 mM MgSO4, 2 mM CaCl2, 11.5 mM glucose, 10 mM 2-deoxy-D-
glucose, 6 mM sodium azide 20 mM HEPES, adjusted to pH 7.4 with NaOH). TCEP solution 
was removed and then cells were treated with 10-4Zn(II) (4 µM, final concentration) for 30 min 
in HBS containing 2-deoxy-D-glucose (10 mM) and sodium azide (6 mM) at 37 °C. Cells were 
washed three times with HBS containing 2 mM pyrophosphate (PPi) (1 mL) to remove unreacted 
10-4Zn(II). HBS containing Cy5-appended B2R antagonist peptide (0.4 µM) was added and cells 
were analyzed by confocal laser scanning microscope (Zeiss, LSM700) using appropriate laser 
and emission filter settings for Oregon Green 488 (lex =488 nm, lem = 490-555 nm) and Cy5 (lex 
= 639 nm, lem > 640 nm). 
 
Evaluation of Non-specific Labeling Property of Probe. In a glass bottom dish, HEK293 cells 
(~ 1 x 106) were incubated in non-serum DMEM containing 2-deoxy-D-glucose (10mM) and 
sodium azide (6 mM) for 30 min at 37 °C in a CO2 incubator. After removal of DMEM, cells 
were treated with TCEP (1 mM) for 10 min at rt in 1 mL HEPES-buffered saline. TCEP solution 
was removed and then cells were treated with 10-4Zn(II) or 11-4Zn(II) (4 µM, final 
concentration) for 10 or 30 min in HBS containing 2-deoxy-D-glucose (10 mM) and sodium azide 
(6 mM) at 37 °C. After washing three times with HBS containing 2 mM PPi (1 mL), the cells 
were fixed by treatment with PBS (100 µL) containing 4% paraformaldehyde, 0.2% 
glutaraldehyde, and 2 mM PPi for 10 min with gentle shaking (80 rpm) at rt. The fixed cells were 
washed three times with HBS containing 0.1% Triton-X and 2 mM pyrophosphate (PPi) (1 mL) 
by gentle shaking (80 rpm) for 10 min at rt. The cells were immersed in HBS (100 µL) and the 
fluorescence on the cell surfaces were detected by confocal laser scanning microscope (Leica, 
TCS SP8) equipped with HyD detector with a high laser power (1%) for Oregon Green 488 (lex 
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=488 nm). The fluorescence image was analyzed by ImageJ software (National Institutes of 
Health) to obtain the fluorescence intensity per area on the cell surface. 
 
EM Detection of B2R in Freeze-fracture Replicas. HEK293T cells (ca. 2 ´  107 cells) transiently 
expressing helixD2-B2R-EGFP, GluA2 (for negative control) or co-expressing helixD2-B2R-
EGFP and GluA2 were washed with HEPES-buffered saline (HBS), and treated with 2 mM TCEP 
in HBS (1 mL) for 10 min at 37 °C. After removal of TCEP solution, the cells were treated with 
3 µM 12-4Zn(II) in HBS for 30 min at 37 °C, or with 3 µM 13-4Zn(II) in HBS for 2 h at 37 °C. 
After washing with HBS containing 2 mM PPi, the cells labeled with 12-4Zn(II) were incubated 
with 1.4-nm gold particle-conjugated streptavidin (Nanoprobes) for 1 h at 37 °C. For estimation 
of chemical labeling density in unfixed cells, cells were fixed after chemical labeling (after 
washing out the 13-4Zn(II) with PPi) and for estimation of chemical labeling density in fixed 
cells, fixation was performed before chemical labeling (before HBS washing). Fixation was done 
with 2% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min at RT. The cells were 
harvested by scraping, collected by centrifugation (100g, 5 min), and the cell pellet was 
sandwiched between gold carriers for high-pressure freezing (HPM010, Bal-Tec). The frozen 
pellet was then fractured into two parts at –120 °C and replicated by depositions of 30 nm carbon 
layer using freeze-fracture replica machine (BAF 060, Bal-Tec). After thawing, the replicas were 
washed with 2.5% SDS, 20% sucrose, and 15 mM Tris-HCl (pH 8.3) under the following 
conditions: 48 h at 60 °C for labeling with 13-4Zn(II); 3 d at 60 °C for labeling of pre-fixed cells 
with 12-4Zn(II); and 18 h at 60 °C for labeling with 12-4Zn(II).  
For EM detection of 1.4-nm gold particle-conjugated streptavidin, the replicas were treated with 
reagents from a silver intensification kit (HQ Silver, Nanoprobes). For immunolabeling, the 
replicas were treated with mouse anti-GFP (CLONTECH), rabbit anti-FLAG (Sigma-Aldrich) or 
rabbit anti-GluA2 antibodies (Figure S9) for 48 h at 15 °C, followed by staining with anti-mouse 
secondary antibody conjugated with 5-nm gold particles or anti-rabbit secondary antibody 
conjugated with 10-nm gold particles (British Biocell International). The silver-intensified 
replicas were analyzed by EM using Tecnai 10/12 transmission electron microscope (FEI); those 
without silver intensification were analyzed by JEM-2800 scanning transmission electron 
microscope (JEOL) in dark field mode. For quantitative analysis of particle distribution, we 
used GPDQ software (Wickman et al., 2018) to calculate the density and NND of particles, 
particle number per cluster, and cluster area. For the definition of clusters of particles, we used 3 
particles as a minimum number and mean + 2SD (Miki et al., 2017; Wickman et al., 2018) of 
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fitted peaks of NND (Figure 5I) as a maximum distance allowed (6 + 3×2 = 12 nm for chemical 
labeling, 22 + 10×2 = 42 nm for immunolabeling). 
 
EM Detection of B2R in Embedded Ultrathin Sections. HEK293 cells (ca. 2 ´ 107 cells) 
transiently expressing helixD2-B2R-EGFP cultured on a coverslip were treated with 2 mM TCEP 
in HBS for 10 min at 37 °C. After removal of the solution, the cells were treated with 3 µM 13-
4Zn(II) for 2 h at 37 °C, and washed with 2 mM PPi in HBS. The cells were then fixed in PBS 
containing 4% paraformaldehyde and 0.05% glutaraldehyde for 10 min at rt. After 3-6 min silver 
intensification, the cells were treated with 0.2% OsO4 in PBS for 20 min, counterstained with 
0.25% uranyl acetate overnight at 4 °C, dehydrated in ascending series of EtOH and propylene 
oxide, and embedded in Durcupan (Sigma-Aldrich). Ultrathin sections (70-µm thick) prepared 
using ultramicrotome (Leica Ultracut UCT, Leica) were counterstained with lead citrate and 
uranyl acetate, and analyzed by Tecnai 10 transmission electron microscope (FEI). For 
immunolabeling of the FLAG tag, HEK293 cells were fixed by 4% paraformaldehyde and 0.05% 
glutaraldehyde in PBS for 10 min at rt. After blocking with 10% normal goat serum and 2% 
bovine serum albumin in Tris-buffered saline (TBS), the cells were treated with anti-FLAG 
antibody (Sigma-Aldrich) followed by anti-mouse secondary antibody conjugated with 1.4-nm 
gold particles (Nanoprobes). After 3-6 min silver intensification, the cells were treated, sectioned 
and observed in the same way as described above. To measure the distance between gold particles 
and cell membrane, we first tilted the ultrathin sections to obtain perpendicular views of lipid 
bilayer (Figure 6B and 6D). We discarded the particles if it was not possible to obtain 
perpendicular views. Then, the distance between the center of silver-intensified gold particles and 
the midpoint of plasma membrane was determined by ImageJ v1.51 software (National Institutes 
of Health). 
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Construction of expression-vectors of the tag-fused maltose binding protein (MBP) 
DNA encoding helixD2-tag (KKCPYSAADAAADAAADAAAD) was introduced into the 
pMAL-c2X vector (New England BioLabs) encoding D4-tag fused MBP (Nonaka et al., 2010) 
by inverse polymerase chain reaction (PCR). After digestion of the template plasmid by the 
treatment with Dpn I, 5’-termini of the PCR product were phosphorylated by T4 polynucleotide 
kinase and then cyclized by DNA ligase to give the vector encoding  helixD2-tag fused MBP. 
The DNA sequence of the vectors was confirmed by 3130xl Genetic Analyzer (Applied 
Biosystems).  
 
Expression and purification of tag-fused MBP 
pMAL-c2X vector encoding helixD2-tag fused MBP was transformed into T7 Expression 
lysY/Iq competent E. coli (New England BioLabs). Single colony was cultured at 37 °C in 2YT 
media (200 mL) containing ampicillin (100 mg/L) at 37 °C until optical density (OD) at 600 nm 
increased to 0.6. and further grown at 37 °C for 6 h with IPTG induction (1 mM final conc.). Cells 
were spun down for 10 min at 13,500 rpm and re-suspended in equilibrium buffer (20 mM Tris–
HCl, 200 mM NaCl, 1mM EDTA, 1mM DTT, pH 8.0) and then lysed by sonication (150 shots x 
2) on ice. Insoluble materials were removed by centrifugation (13,500 rpm, 10 min) and 
supernatant was applied to a MBPTrap affinity column (GE Healthcare). Column was washed 
with equilibrium buffer (x2) and then MBP was eluted by elusion buffer (20 mM Tris–HCl, 200 
mM NaCl, 10 mM maltose, pH 8.0). Purity of MBP in fractions was checked by SDS-PAGE. 
Concentration of purified MBP was determined by the UV absorbance at 280 nm using the 
calculated extinction coefficient (e280nm = 69,330 M-1cm-1). MBP solution was kept at 4 °C in the 
presence of 1 mM TCEP. 
 
Construction of vectors of tag-fused B2R receptor 
DNA encoding helixD2-tag (KKCPYSAADAAADAAADAAAD) or CH6 tag inserted into 
pCIneo plasmid encoding α7-D4-B2R vector (Nonaka et al., 2010) by inverse polymerase chain 
reaction (PCR). After digestion of template plasmid by the treatment with Dpn I, 5’-termini of 
the PCR product were phosphorylated by T4 polynucleotide kinase and then cyclized by DNA 
ligase to give the vector encoding α7-helixD4-B2R or α7-CH6-B2R. DNA sequences were 
confirmed by 3130xl Genetic Analyzer (Applied Biosystems). 
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Solid-Phase Peptide Synthesis 
Peptides except for peptide-c were synthesized by solid-phase peptide synthesis using standard 
Fmoc-based coupling chemistry. Coupling reactions (0.2 mmol scale) were performed using 4 
equiv of amino acid, 4 equiv of HOBt and 4 equiv of HBTU on Rink Amide MBHA Resin LL 
(0.2 mmol, 0.38 mmol/g, Merck Millipore). N-terminal was acetylated by treatment with 20 equiv 
of Ac2O in NMP.  Peptide cleavage and deprotection were carried out by treatment of resin with 
TFA / H2O / triisopropylsilane (95 : 2.5 : 2.5) for 3 h at rt. The crude peptide was collected by 
precipitation in tert-butyl methyl ether and purified by reverse-phase HPLC (column; YMC-pack 
ODS-A, 20 x 250 mm) using CH3CN (0.1% TFA) / H2O (0.1% TFA) solvent system with a linear 
gradient mode. Typical HPLC conditions are as follows; 5 / 95 (0 min) →5 / 95 (10 min) → 40 / 
60 (50 min), flow rate 9.9 mL/min, UV detection at 220 nm. Purified peptide was lyophilized and 
stocked in a refrigerator (-30 °C).  
 
MALDI-TOF-MS analysis (CHCA) 
peptide-a: calcd for C57H84N16O25 (MW; 1392.6), found 1416.3 [M+Na]+. 
peptide-b1a: calcd for C54H87N17O24 (MW; 1357.6), found 1358.7 [M+H]+. 
peptide-d: calcd for C68H102N20O29S (MW; 1694.7), found 1694.3 [M]+.  
peptide-e: calcd for C69H102N20O29S (MW; 1706.7), found 1706.8 [M]+.  
peptide-f: calcd for C70H104N20O29S (MW; 1720.7), found 1719.8 [M-H]-. 
peptide-g: calcd for C77H120N22O30S (MW; 1864.8), found 1864.2 [M-H]-. 
peptide-h: calcd for C77H120N26O30S (MW; 1920.8), found 1920.2 [M-H]-. 
peptide-i: calcd for C68H95N19O36S (MW; 1785.6), found 1783.1 [M-H]-. 
peptide-j: calcd for C80H125N23O31S (MW; 1935.9), found 1937.0 [M] -. 
peptide-k: calcd for C83H130N24O32S (MW; 2006.9), found 2005.5. [M-H] -. 
 a) peptide-b1 is a peptide that lacks 7-hydroxycumarin from peptide-b. 
 
Conjugation of peptide-b1 with 7-hydroxycumarine 
A solution of the peptide-b1 (3 mg, 2.21 µmol), 7-hydroxycumarine succinimidyl ester (3.3 
mg, 11.1 µmol) and DIEA (438 µL, 1.16 mmol) in dry DMF (2 mL) was stirred overnight at rt. 
H2O (1.5 mL) was added, the solution was stirred for 1 h at rt. Purification was conducted by 
HPLC (column; YMC-Actus Triart C18, 20 x 250 mm) using CH3CN (0.1% TFA) / H2O (0.1% 
 S16 
TFA) solvent system with a linear gradient mode. The collected fractions were lyophilized to give 
peptide-b.  
HPLC conditions: column; YMC-Actus Triart C18, 250 x 20 mm, mobile phase; CH3CN 
(containing 0.1% TFA) / H2O (containing 0.1% TFA) = 5 / 95(0-10 min) → 60 / 40 (linear 
gradient over 50 min), MALDI-TOF-MS: calcd for C64H91N17O28 1545.6, found 1544.5 [M-H]-. 
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General Materials and Methods for Organic Synthesis 
Unless otherwise noted, chemical reagents were purchased from commercial suppliers (Tokyo 
Chemical Industry (TCI), Wako Pure Chemical Industries, Watanabe Chemical Industries, and 
Sigma-Aldrich) and used without further purification. 1H-NMR spectra were recorded using 
Varian UNITY-400 (400 MHz) spectrometer, and chemical shifts (δ, ppm) were referenced to 
residual solvent peak. ESI and MALDI-TOF mass spectra were measured using Bruker 
micrOTOF II and Bruker autoflex III spectrometer, respectively. HPLC purification was 
conducted with Hitachi L-7100. Compound 6, 15 and 18 were synthesized according to the 
previous report (Nonaka et al., 2010). 
 
 
Synthesis of 16 
To a solution of Boc-bAla-OH (185 mg, 0.98 mmol) in dry DMF (5 mL) was added WSCI•
HCl (188 mg, 0.98 mmol), HOBt•H2O (150 mg, 0.98 mmol), DIEA (391 µL, 2.4 mmol) and 15 
(433 mg, 0.70 mmol). The solution was stirred overnight at rt. After dilution with AcOEt, the 
mixture was washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After 
removal of the solvent by evaporation, the residue was purified by column chromatography on 
SiO2 (CHCl3 : MeOH : NH3 = 400 : 10 : 1 → 300 : 10 : 1) to give 16 (410 mg, 73%) as a colorless 
amorphous powder. 
1H-NMR(400 MHz, CDCl3): δ 10.99 (1H, br), 8.50 (4H, s), 7.56 (4H, t, J = 7.4 Hz), 7.42 (4H, d, 
J = 7.6 Hz), 7.09 (4H, t, J = 5.8 Hz), 6.94 (2H, s), 6.71 (1H, d, J = 8.0 Hz), 5.26 (1H, br), 4.74 
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(1H, m), 3.83 (8H, s), 3.75 (4H, s), 3.65 (3H, s), 3.25 (2H, d, J = 5.6 Hz), 3.01 (2H, t, J = 8.8 Hz), 
2.21 (2H, m), 1.37 (9H, s). ESI-TOF-MS m/z [M + Na]+ calcd for C44H52N8O6Na 811.39; Found 
811.39. 
 
Synthesis of 17 
To an ice-cooled solution of 16 (410 mg, 510 µmol) in CH2Cl2 (2.5 mL) was added dropwise 
TFA (2.5 mL) and the solution was stirred for 1 h at rt. The solvent was removed in vacuo and 
the residue was dissolved in H2O. The mixture was neutralized with aq. NH3 on ice-cooling and 
then extracted with CH2Cl2. The organic layer was washed with brine followed by drying over 
Na2SO4. The solution was concentrated by evaporation to give 17 (330 mg, 92%) as a colorless 
amorphous powder. 
1H-NMR (400 MHz, CDCl3) : δ 10.90 (1H, br), 8.47 (4H, s), 8.25 (1H, br), 7.51 (4H, t, J = 7.4 
Hz), 7.30 (4H, d, J = 7.6 Hz), 7.07 (4H, t, J = 6.0 Hz), 6.93 (2H, s), 4.66 (1H, br), 3.86 (4H, m), 
3.65 (11H, m), 2.93 (4H, m), 2.59 (1H, br), 2.33 (1H, m). ESI-TOF-MS m/z [M + Na]+ calcd for 
C39H45N8O4Na 689.36; Found 689.36.  
 
Synthesis of 2 
To a solution of 18 (430 mg, 0.61 mmol) in dry DMF (5 mL) was added WSCI•HCl (115 mg, 
0.61 mmol), HOBt•H2O (93 mg, 0.61 mmol), DIEA (246 µL, 1.41 mmol) and 17 (330 mg, 0.47 
mmol). The solution was stirred overnight at rt. After dilution with AcOEt, the mixture was 
washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After removal of the 
solvent by evaporation, the residue was purified by column chromatography on SiO2 (CHCl3 : 
MeOH : NH3 = 300 : 10 : 1→200 : 10 : 1) to give 2 (450 mg, 70%) as a colorless amorphous 
powder. 
1H-NMR(400 MHz, CDCl3): δ 10.95 (2H, br), 8.47 (8H, s), 7.56 (8H, m), 7.40 (8H, t, J = 6.4 Hz), 
7.14 (1H, br), 7.04 (10H, m), 6.95 (2H, s), 5.36 (1H, br), 4.65 (1H, m), 4.23 (1H, br), 3.73 (25H, 
m), 3.57 (3H, s), 3.46 (1H, s), 3.16 (1H, br), 2.91 (4H, m), 2.11 (2H, m), 1.24 (9H, s). ESI-TOF-
MS 1396.66 [M + H]+. 13C NMR (125 MHz, CDCl3) δ 173.1, 172.1, 172.0, 159.1, 155.7, 155.1, 
155.0, 149.0, 136.9, 130.4, 130.3, 126.5, 126.0, 124.0, 123.3, 123.3, 122.2 x 2, 79.7, 59.7, 56.4, 
54.9, 54.8, 54.1, 52.3, 37.9, 36.5, 35.9, 35.8, 28.3. ESI-TOF-MS m/z [M + Na]+ calcd for 
C79H87N15O8Na 1396.68; Found 1396.66. 
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Synthesis of 3 
To an ice-cooled solution of cinnamic acid (12 mg, 81 µmol) in dry DMF (1.5 mL) was added 
triethylamine (11 µL, 81 µmol), Py-BOP (36 mg, 81 µmol) and 15 (50 mg, 81 µmol). The solution 
was stirred for 3 h at rt. After dilution with AcOEt, the mixture was washed with saturated 
NaHCO3 and brine followed by drying over Na2SO4. After removal of the solvent by evaporation, 
the residue was purified by column chromatography on SiO2 (CHCl3 : MeOH : NH3 = 400 : 10 : 
1) to give 3 (52 mg, 86%) as a colorless amorphous powder. 
1H-NMR(400 MHz, DMSO-d6): δ 10.94 (1H, s), 8.49-8.45 (5H, m), 7.68 (4H, t, J = 7.2 Hz), 7.44-
7.32 (9H, m), 7.20 (4H, t, J = 6.0 Hz), 7.05 (2H, s), 6.65 (1H, d, J = 16 Hz), 4.6 (1H, q, J = 13.6 
Hz, 6.4 Hz), 3.73 (8H, s), 3.64 (4H, s), 3.52 (3H, s), 2.98-2.85 (1H, m). ESI-TOF-MS m/z [M + 
H]+ calcd for C45H46N7O4 748.36; Found 748.38. 
 
Synthesis of 4 
To an ice-cooled solution of crotonic acid (4.1 mg, 48 µmol) in dry DMF (1.5 mL) was added 
a mixture of triethylamine (6.7 µL, 48 µmol), Py-BOP (22 mg, 48 µmol) and 15 (30 mg, 48 µmol). 
The solution was stirred for 28 h at rt. After dilution with AcOEt, the mixture was washed with 
saturated NaHCO3 and brine followed by drying over Na2SO4. After removal of the solvent by 
evaporation, the residue was purified by column chromatography on SiO2 (CHCl3 : MeOH : NH3 
= 250 : 10 : 1) to give a pale yellow oil (24 mg). This oil was further purified by column 
chromatography on SiO2 (CHCl3 : MeOH : NH3 = 350 : 10 : 1) to give 4 (7 mg, 21%) as a pale 
yellow oil. 
1H-NMR(400 MHz, CDCl3): δ 10.94 (1H, br), 8.52 (4H, d, J = 4.8 Hz), 7.60 (4H, t, J = 7.6 Hz), 
7.44 (4H, d, J = 8.0 Hz), 7.11 (4H, t, J = 6.4 Hz), 6.97 (2H, s), 6.80-6.74 (1H, m), 6.41 (1H, d, J 
= 7.6 Hz), 4.86 (1H, q, J = 13.6 Hz, 7.6 Hz), 3.85 (8H, s), 3.76 (4H, s), 3.65 (3H, s), 3.05 (2H, d, 
J = 5.2 Hz), 1.68 (3H, d, J = 6.8 Hz). ESI-TOF-MS m/z [M + H]+ calcd for C40H44N7O4 686.34; 
Found 686.36. 
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Synthesis of 5 
To an ice cooled solution of 4-(dimethylamino)-2-butenoic acid hydrochloride (13 mg, 80 
µmol) in dry DMF (1.5 mL) was added DIEA (44 µL, 240 µmol), Py-BOP (36 mg, 80 µmol) and 
15 (50 mg, 80 µmol). The solution was stirred for 44 h at rt. After dilution with AcOEt, the 
mixture was washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After 
removal of the solvent by evaporation, the residue was purified by column chromatography on 
SiO2 (CHCl3 : MeOH : NH3 = 300 : 10 : 1→150 : 10 : 1) to give 5 (56 mg, 95%) as a pale yellow 
oil. 
1H-NMR(400 MHz, CDCl3): δ 8.52 (4H, d, J = 4.8 Hz), 7.58 (4H, t, J = 8.0 Hz), 7.44 (4H, d, J = 
8.0 Hz), 7.10 (4H, t, J = 6.0 Hz), 6.97 (2H, s), 6.80-6.74 (1H, m), 6.57 (1H, d, J = 7.6 Hz), 4.86 
(1H, q, J = 13.2 Hz, 5.6 Hz), 3.84 (8H, s), 3.76 (4H, s), 3.65 (3H, s), 3.05 (2H, d, J = 6.0 Hz), 
2.89 (2H, m), 2.14 (6H, s). ESI-TOF-MS m/z [M + H]+ calcd for C42H49N8O4 729.39; Found 
729.40. 
 
 
Synthesis of 19 
To an ice-cooled solution of 2 (300 mg, 0.24 mmol) in dry CH2Cl2 (2.0 mL) was added 
dropwise TFA (2.5 mL) and the solution was stirred for 1 h at rt. After removal of the solvent in 
vacuo, the residue was dissolved in H2O. The mixture was neutralized with aqueous NH3 on ice-
cooling and then extracted with CH2Cl2. The organic layer was washed with brine followed by 
drying over Na2SO4. The solution was concentrated by evaporation to give 19 (250 mg, 90%) as 
a colorless amorphous powder. 
1H-NMR (400 MHz, CDCl3) : δ 10.96 (2H, br), 8.50 (8H, t, J = 2.4 Hz), 7.76 (1H, m), 7.59 (8H, 
t, J = 7.6 Hz), 7.45 (8H, t, J = 8.0 Hz), 7.10 (8H, t, J = 6.0 Hz), 7.03 (2H, s), 6.97 (2H, s), 4.77 
(1H, dd, J = 6.8 Hz), 3.84 (16H, s), 3.80-3.73 (9H, m), 3.62 (3H, s), 3.44-3.35 (4H, m), 3.11-2.98 
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(4H, m), 2.56-2.50 (1H, m), 2.25-2.24 (2H, m). ESI-TOF-MS m/z [M + H]+ calcd for C74H80N15O6 
1274.64; Found 1274.66. 
 
Synthesis of 7 
To an ice-cooled solution of 4-(dimethylamino)-2-butenoic acid hydrochloride (3.8 mg, 25 
µmol) in dry DMF (1.0 mL) was added DIEA (12 µL, 63 µmol), Py-BOP (12 mg, 24 µmol) and 
19 (20 mg, 16 µmol). The solution was stirred for 38 h at rt. After dilution with AcOEt, the 
solution was washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After 
removal of the solvent by evaporation, the residue was purified by column chromatography on 
SiO2 (CHCl3 : MeOH : NH3 = 400 : 4 : 1→180 : 30 : 1) to give 7 (12 mg, 53%) as a colorless oil. 
1H-NMR (400 MHz, DMSO-d6) : δ 10.93 (1H, s), 10.81 (1H, s), 8.45 (8H, d, J = 4.8 Hz), 8.30 
(1H, d, J = 9.2 Hz), 8.12 (1H, d, J = 8.4 Hz), 7.98 (1H, m), 7.68 (8H, t, J = 7.2 Hz), 7.42 (8H, d, 
J = 7.6 Hz), 7.20 (8H, dd, J = 1.4 Hz, 6.2 Hz), 7.03 (2H, s), 6.99 (2H, s), 6.36-6.33 (1H, m), 5.96 
(1H, d, J = 15.6 Hz), 4.50-4.40 (2H, m), 3.71 (16H, d, J = 8.4 Hz), 3.61 (8H, d, J = 11.2 Hz), 3.42 
(3H, s), 3.15-3.14 (4H, m), 2.88-2.62 (8H, m), 2.24-2.14 (4H, m), 1.93 (6H, s). ESI-TOF-MS m/z 
[M + H]+ calcd for C80H19N16O7 1385.71; Found 1385.72. 
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Synthesis of 21 
To an ice-cooled solution of 20 (13 mg, 47 µmol) in dry DMF (1.5 mL) was added DIEA (23 
µL, 126 µmol), Py-BOP (25 mg, 47 µmol) and 19 (40 mg, 31 µmol) and the solution was stirred 
for 13 h at rt. After dilution with AcOEt, the solution was washed with saturated NaHCO3 and 
brine followed by drying over Na2SO4. After removal of the solvent by evaporation, the residue 
was purified by column chromatography on SiO2 (CHCl3 : MeOH : NH3 = 400 : 4 : 1→160 : 20 : 
1) to give 21 (44 mg, 33%) as a colorless oil. This material contained a small amount of impurities 
but was used for the next reaction without further purification. 
1H-NMR (400 MHz, DMSO-d6) : δ 10.93 (1H, s), 10.87 (1H, s), 8.45 (8H, d, J = 3.6 Hz), 8.31 
(1H, d, J = 7.6 Hz), 8.06 (1H, t), 7.68 (8H, t, J = 7.6 Hz), 7.50 (1H, d, J = 8.0 Hz), 7.42 (8H, d, J 
= 7.6 Hz), 7.20 (8H, dd, J = 1.6 Hz, 6.0 Hz), 6.98 (4H, d, J = 2.4 Hz), 6.73 (1H, t), 4.51-4.39 (2H, 
m), 3.73 (16H, s), 3.63 (8H, d, J = 2.8 Hz), 3.42 (3H, s), 3.15 (4H, m), 2.89-2.66 (6H, m), 2.31-
2.07 (4H, m), 1.32 (9H, s). ESI-TOF-MS m/z [M + H]+ calcd for C85H96N16O11 1520.77; Found 
1520.78. 
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Synthesis of 22 
To an ice-cooled solution of the crude 21 (43 mg) in CH2Cl2 (1 mL) was added dropwise TFA 
(1 mL) and the solution was stirred for 1 h at rt. After removal of the solvent in vacuo, the residue 
was dissolved in H2O. The mixture was neutralized with aq. NH3 on ice-cooling and extracted 
with CH2Cl2 (x2). The organic layer was washed with brine followed by drying over Na2SO4. The 
solution was concentrated by evaporation to give 22 (41 mg, quant) as a colorless oil. This 
material contained a small amount of impurities but was used for the next reaction without further 
purification. 
1H-NMR (400 MHz, CDCl3) : δ 11.03 (2H, br), 8.49 (8H, t, J = 5.6 Hz), 7.58 (8H, dd, J = 8.0 Hz, 
11.6 Hz), 7.42 (8H, t, J = 7.2 Hz), 7.37 (1H, t, J = 7.2 Hz), 7.12-7.08 (8H, m), 7.02 (2H, s), 6.98 
(2H, s), 4.64-4-57 (2H, m), 3.83 (16H, s), 3.77-3.71 (8H, m), 3.56 (3H, s), 3.55-3.46 (6H, m), 
3.10-2.82 (8H, m), 2.20-2.04 (4H, m). ESI-TOF-MS m/z [M + H]+ calcd for C80H91N16O9 1419.71; 
Found 1419.73. 
 
Synthesis of 8 
To an ice-cooled solution of 4-(dimethylamino)-2-butenoic acid hydrochloride (3.4 mg, 21 
µmol) in dry DMF (1 mL) was added DIEA (10 µL, 56 µmol), Py-BOP (11 mg, 21 µmol) and 
the crude 22 (20 mg). The solution was stirred for 14.5 h at rt. After dilution with AcOEt, the 
solution was washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After 
removal of the solvent by evaporation, the residue was purified by column chromatography on 
SiO2 (CHCl3 : MeOH : NH3 = 400 : 4 : 1→200 : 4 : 1→180 : 30 : 1) to give 8 (7 mg, 33%) as a 
colorless oil. 
1H-NMR (400 MHz, DMSO-d6) : δ 10.93 (1H, s), 10.88 (1H, s), 8.46 (8H, d, J = 3.6 Hz), 8.46 
(8H, d, J = 3.6 Hz), 8.36 (1H, m), 8.20 (1H, m), 8.02 (1H, m), 7.68 (8H, t, J = 7.2 Hz), 7.52 (1H, 
d), 7.41 (8H, d, J = 8.0 Hz), 7.20 (8H, d, J = 7.6 Hz), 6.98 (4H, s), 6.52 (1H, m), 6.06 (1H, m), 
4.56-4.38 (4H, m), 3.72-3.63 (26H, m), 3.42 (3H, s), 3.15 (4H, m), 2.90 (6H, m), 2.30-2.11 (4H, 
m), 2.06 (6H, s). ESI-TOF-MS m/z [M + H]+ calcd for C86H100N17O10 1530.78; Found 1530.78. 
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Synthesis of 23 
To an ice-cooled solution of 19 (20 mg, 16 µmol) in dry DMF (1.0 mL) was added WSCI•HCl 
(3.6 mg, 19 µmol), HOBt•H2O (2.9 mg, 19 µmol), DIEA (12 µL, 75 µmol) and Boc-L-Pro (4 mg, 
19 µmol). The solution was stirred for 13 h at rt. After dilution with AcOEt, the solution was 
washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After removal of the 
solvent by evaporation, the residue was purified by column chromatography on SiO2 (CHCl3 : 
MeOH : NH3 = 400 : 4 : 1→160 : 20 : 1) to give 23 (22 mg, 95%) as a colorless amorphous 
powder.  
1H-NMR (400 MHz, CDCl3) : δ 10.98 (2H, br), 8.49 (8H, d, J = 4.0 Hz), 7.58 (8H, dd, J = 8.0 
Hz, 11.6 Hz), 7.45 (8H, t, J = 6.8 Hz), 7.12-7.08 (8H, m), 6.99 (4H, s), 6.77 (2H, m), 4.68-4.53 
(2H, m), 4.11 (1H, m), 3.83-3.75 (24H, m), 3.57 (3H, s), 3.20-2.96 (10H, m), 2.22 (4H, m), 1.62 
(9H, br). ESI-TOF-MS m/z [M + H]+ calcd for C84H95N16O9 1472.75; Found 1472.75. 
 
Synthesis of 24 
To an ice-cooled solution of 23 (20 mg, 13.6µmol) in CH2Cl2 (1 mL) was added dropwise TFA 
(1 mL) and the solution was stirred for 1 h at rt. After removal of the solvent in vacuo, the residue 
was dissolved in H2O. The mixture was neutralized with aq. NH3 on ice-cooling and extracted 
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with CH2Cl2. The organic layer was washed with brine followed by drying over Na2SO4. The 
solution was concentrated by evaporation to give 24 (24 mg, quant) as a colorless oil. 
1H-NMR (400 MHz, CDCl3) : δ 10.95 (2H, br), 8.49 (8H, t, J = 3.2 Hz), 8.02 (1H, m), 7.58 (8H, 
dd, J = 7.2 Hz, 10.4 Hz), 7.45 (8H, t, J = 8.8 Hz), 7.37 (1H, t, J = 8.0 Hz), 7.10-7.02 (8H, m), 
7.00 (5H, s), 4.63 (2H, dd, J = 5.2 Hz), 4.41 (2H, m), 4.11 (1H, m), 3.87-3.75 (24H, m), 3.60 (3H, 
s), 3.22-2.10(14H, m). ESI-TOF-MS m/z [M + H]+ calcd for C79H87N16O7 1371.69; Found 
1371.70. 
 
Synthesis of 9 
To an ice-cooled solution of 4-(dimethylamino)-2-butenoic acid hydrochloride (3.4 mg, 21 
µmol) in dry DMF (1 mL) was added a mixture of DIEA (10 µL, 56 µmol), Py-BOP (11 mg, 21 
µmol) and 24 (22 mg, 14 µmol). The solution was stirred for 18 h at rt. After dilution with AcOEt, 
the solution was washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After 
removal of the solvent by evaporation, the residue was purified by column chromatography on 
SiO2 (CHCl3 : MeOH : NH3 = 400 : 4 : 1→160 : 20 : 1) to give 9 (11 mg, 47%) as a colorless 
amorphous powder. 
1H-NMR (400 MHz, DMSO-d6) : δ 10.94 (2H, d), 8.46 (8H, d), 8.30 (1H, d, J = 10 Hz), 7.79 (1H, 
m), 7.68 (8H, t, J = 7.6 Hz), 7.44 (8H, t, J = 8.0 Hz), 7.21 (8H, t, J = 5.6 Hz), 6.99 (4H, s), 6.58 
(1H, m), 6.32 (1H, m), 4.41 (2H, m), 3.72 (16H, s), 3.64 (8H, s), 3.42 (3H, s), 3.18-2.78 (12H, 
m), 2.12 (6H, br), 1.87 (2H, m). ESI-TOF-MS m/z [M + H]+ calcd for C85H96N17O8 1482.76; 
Found 1482.76. 
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Synthesis of 25 
To an ice-cooled solution of 18 (1.0 g, 1.42 mmol) in dry DMF (6 mL) was added WSCI•HCl 
(355 mg, 1.85 mmol), HOBt•H2O (283 mg, 1.85 mmol), DIEA (0.9 mL, 5.68 mmol) and H-  la-
OMe•HCl (258 mg, 1.85 mmol). The solution was stirred for 6 h at rt. After dilution with AcOEt, 
the solution was washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After 
removal of the solvent by evaporation, the residue was purified by column chromatography on 
SiO2 (CHCl3 : MeOH : NH3 = 300 : 10 : 1 → 200 : 10 : 1) to give 25  (953 mg, 85%) as a 
colorless amorphous powder. 
1H-NMR(400 MHz, CDCl3): δ 10.98 (1H, br), 8.54 (4H, d, J = 4.8 Hz), 7.60 (4H, t, J = 6.8 Hz), 
7.45 (4H, d, J = 8.0 Hz), 7.12 (4H, t, J = 8.0 Hz), 7.04 (2H, s), 5.32 (1H, m), 4.30 (1H, m), 3.90-
3.70 (12H, m), 3.46 (3H, s), 3.31-3.23 (2H, m), 3.02-2.97 (1H, m), 2.87-2.81 (1H, m), 2.34-2.17 
(2H, m), 1.36 (9H, s). ESI-TOF-MS m/z [M + H]+ calcd for C44H53N8O6 789.41; Found 789.41. 
 
Synthesis of 26 
To an ice-cooled solution of 25 (916 mg, 1.16 mmol) in MeOH-H2O (18 : 5 (v/v), 23 mL) was 
added 5 N NaOH (696  L, 3.48 mmol) and the solution was stirred for 7 h at 0 ˚C. After dilution 
with water, the solution was washed with diethyl ether (x2). The pH was adjusted to 5 and 
extracted with CHCl3 (x2). The organic phase was dried over Na2SO4 and concentrated in vacuo. 
The residue was washed with hexane-i-PrOH (1 : 1) to give 26 (804 mg, 89%) as a colorless 
amorphous powder. 
1H-NMR (400 MHz, CDCl3) : δ 8.54 (4H, m), 7.70-7.52 (8H, m), 7.13 (4H, m), 7.01 (2H, s), 6.70 
(1H, m), 5.55 (1H, m), 4.37 (1H, m), 4.00 (12H, m), 3.46 (1H, m), 3.26 (1H, m), 3.09-3.07 (1H, 
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m), 2.76-2.70 (1H, m), 2.22 (2H, m). ESI-TOF-MS m/z [M + H]+ calcd for C43H51N8O6 775.39; 
Found 775.38. 
 
Synthesis of 27 
To an ice-cooled solution of 18 (200 mg, 0.28 mmol) in dry DMF (3.0 mL) was added 
WSCI•HCl (83 mg, 0.43 mmol), HOBt•H2O (64 mg, 0.43 mmol), DIEA (148 µL, 0.85 mmol) 
and 11-azido-3,6,9-trioxaundecan-1-amine (56 µL, 0.28 mmol). The solution was stirred 
overnight at rt. After dilution with AcOEt, the solution was washed with saturated NaHCO3 and 
brine followed by drying over Na2SO4. After removal of the solvent by evaporation, the residue 
was purified by column chromatography on SiO2 (CHCl3 : MeOH : NH3 = 400 : 10 : 1 → 300 : 
10 : 1) to give 27 (211 mg, 82%) as a colorless oil. 
1H-NMR(400 MHz, CDCl3): δ 10.97 (1H, br), 8.53 (4H, d, J = 3.6 Hz), 7.60 (4H, t, J = 7.6 Hz), 
7.45 (4H, d, J = 8.0 Hz), 7.12 (4H, t, J = 7.6 Hz), 7.05 (2H, s), 6.90 (1H, br), 4.33 (1H, m), 3.85 
(8H, s), 3.75 (4H, dd, J = 19.2 Hz, 14 Hz), 3.66-3.24 (19H, m), 3.00-2.86 (2H, m), 1.35 (9H, s). 
ESI-TOF-MS m/z [M + H]+ calcd for C48H62N11O7 904.48; Found 904.50. 
 
Synthesis of 28 
To an ice-cooled solution of 27 (210 mg, 232 µmol) in CH2Cl2 (1.5 mL) was added dropwise 
TFA (1.5 mL) and the solution was stirred for 1 h at rt. After removal of the solvent in vacuo, the 
residue was dissolved in H2O. The mixture was neutralized with aq. NH3 on ice-cooling, diluted 
with saturated NaHCO3, and then extracted with CH2Cl2 (x2). The organic layer was dried over 
Na2SO4. The solution was concentrated by evaporation to give 28 (176 mg, 96%) as a pale yellow 
oil. 
1H-NMR (400 MHz, CDCl3) : δ 10.99 (1H, br), 8.51 (4H, d, J = 4.8 Hz), 7.63-7.59 (4H, m), 7.47 
(4H, d, J = 8.0 Hz), 7.11 (4H, t, J = 6.4 Hz), 7.05 (2H, s), 3.86 (8H, s), 3.80 (4H, s), 3.69-3.34 
(16H, m), 3.18-3.14 (2H, m), 2.58-2.51 (1H, m). ESI-TOF-MS m/z [M + H]+ calcd for 
C43H54N11O5 804.43; Found 804.44. 
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Synthesis of 29 
To a solution of 28 (99 mg, 132 µmol) in dry DMF (2 mL) was added WSCI•HCl (36 mg, 185 
µmol), HOBt•H2O (28 mg, 185 µmol), DIEA (86 µL, 492 µmol) and 26 (115 mg, 148 µmol). The 
solution was stirred overnight at rt. After dilution with AcOEt, the solution was washed with 
saturated NaHCO3 and brine followed by drying over Na2SO4. After removal of the solvent by 
evaporation, the residue was purified by column chromatography on SiO2 (CHCl3 : MeOH : NH3 
= 200 : 10 : 1) to give 29 (140 mg, 73%) as a colorless amorphous powder. 
1H-NMR (400 MHz, CDCl3) : δ 10.99 (2H, br), 8.54-8.51 (8H, m), 7.61-7.58 (8H, m), 7.52-7.43 
(8H, m), 7.14-7.02 (12H, m), 5.44 (1H, m), 4.62-4.60 (1H, m), 4.29 (1H, m), 3.84-3.18 (42H, m), 
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2.95-2.85 (6H, m), 2.27-2.17 (2H, m), 1.27 (9H, s). ESI-TOF-MS 1561.78 [M + H]+. ESI-TOF-
MS m/z [M + H]+ calcd for C86H102N19O10 1561.88; Found 1561.78. 
 
Synthesis of 30 
To an ice-cooled solution of 29 (139 mg, 89 µmol) in CH2Cl2 (2 mL) was added dropwise TFA 
(2 mL) and the solution was stirred for 2 h at rt. After removal of the solvent in vacuo, the residue 
was dissolved in H2O. The mixture was neutralized with aq. NH3 on ice-cooling, diluted with 
saturated NaHCO3, and then extracted with CH2Cl2. The organic layer was dried over Na2SO4. 
The solution was concentrated by evaporation to give 30 (130 mg, quant) as a pale red amorphous 
powder. 
1H-NMR (400 MHz, CDCl3) : δ 10.99 (2H, br), 8.50 (8H, dd, J = 7.6 Hz, 4.0 Hz), 7.62-7.57 (8H, 
m), 7.48-7.43 (8H, t, J = 8.8 Hz), 7.14-7.02 (12H, m), 4.66 (1H, m), 3.84-3.06 (46H, m), 2.96-
2.86 (2H, m), 2.31 (2H, m). ESI-TOF-MS m/z [M + H]+ calcd for C81H94N19O8 1460.75; Found 
1460.76. 
 
Synthesis of 31 
To an ice-cooled solution of 30 (40 mg, 27 µmol) in dry DMF (1.5 mL) was added WSCI•HCl 
(6.4 mg, 33 µmol), HOBt•H2O (5 mg, 25 µmol), DIEA (22 µL, 132 µmol) and Boc-L-Pro (7 mg, 
33 µmol). The solution was stirred for 4.5 h at rt. After dilution with AcOEt, the solution was 
washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After removal of the 
solvent by evaporation, the residue was purified by column chromatography on SiO2 (CHCl3 : 
MeOH : NH3 = 400 : 4 : 1 → 160 : 20 : 1) to give 31 (34 mg, 75%) as a pale yellow oil. 
1H-NMR (400 MHz, CDCl3) : δ 10.95-10.94 (2H, m), 8.52 (8H, t, J = 4.0 Hz), 7.58 (8H, t, J = 
7.6 Hz), 7.44 (8H, t, J = 6.8 Hz), 7.32 (1H, m), 7.13-7.11 (8H, t, J = 5.2 Hz), 7.02-7.00 (3H, m), 
6.72 (1H, m), 4.60-4.52 (2H, m), 4.11 (1H, m), 3.83 (16H, s), 3.71-3.18 (28H, m), 2.90-2.89 (3H, 
m), 2.25 (1H, m), 1.93 (2H, m), 1.71 (13H, m). ESI-TOF-MS m/z [M + H]+ calcd for 
C91H109N20O11 1658.86; Found 1658.89. 
 
Synthesis of 32 
To an ice-cooled solution of 31 (32 mg, 19 µmol) in dry CH2Cl2 (1.0 mL) was added dropwise 
TFA (1.0 mL) and the solution was stirred for 1 h at rt. After removal of the solvent in vacuo, the 
residue was dissolved in H2O. The mixture was neutralized with aq. NH3 on ice-cooling, diluted 
with saturated NaHCO3, and then extracted with CH2Cl2 (x2). The organic layer was washed with 
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brine and dried over Na2SO4. The solution was concentrated by evaporation to give 32 (32 mg, 
quant) as a colorless oil.  
1H-NMR (400 MHz, CDCl3) : δ 10.95 (2H, brs), 8.51 (8H, t, J = 5.2 Hz), 8.04 (1H, m), 7.58 (8H, 
t, J = 8.0 Hz), 7.43 (8H, t, J = 8.0 Hz), 7.14-7.10 (8H, m), 7.04 (4H, s), 4.57-4.47 (2H, m), 3.83 
(16H, s), 3.80-2.52 (31H, m), 2.27-1.66(7H, m). ESI-TOF-MS m/z [M + H]+ calcd for 
C86H101N20O9 1558.81; Found 1558.84. 
 
Synthesis of 33 
To an ice-cooled solution of 4-(dimethylamino)-2-butenoic acid hydrochloride (7.0 mg, 43 
µmol) in dry DMF (1 mL) was added DIEA (19 µL, 116 µmol), Py-BOP (22 mg, 43 µmol) and 
32 (30 mg, 19 µmol). The solution was stirred overnight at rt. After dilution with water, the 
solution was washed with saturated NaHCO3 and brine followed by drying over Na2SO4. After 
removal of the solvent by evaporation, the residue was purified by column chromatography on 
SiO2 (CHCl3 : MeOH : NH3 = 400 : 4 : 1→160 : 20 : 1) to give 33 (19 mg, 60%) as a colorless 
oil. 
1H-NMR (400 MHz, CDCl3) : δ 10.95 (2H, br), 8.50 (8H, dd, J = 11.2 Hz, 4.4 Hz), 7.58 (8H, t, J 
= 7.6 Hz), 7.43 (8H, t, J = 8.4 Hz), 7.34-7.32 (2H, m), 7.13-7.09 (8H, m), 7.01 (4H, d, J = 5.2 
Hz), 6.80-6.74 (1H, m), 4.60-4.58 (1H, m), 4.38 (2H, m), 3.83 (16H, s), 3.79-3.01 (28H, m), 2.88-
2.84 (2H, m), 2.39-2.35 (1H, m), 2.21 (8H, br), 1.75 (4H, m). ESI-TOF-MS m/z [M + H]+ calcd 
for C92H110N21O10 1669.88; Found 1669.91. 
 
Synthesis of 14 
A solution of 33 (18 mg, 11µmol) and Pd/C-ethylenediamine complex (10 mg) in MeOH-
CH2Cl2 (1 : 1, 5 mL) was vigorously stirred for 5 h under H2 atmosphere at rt. After filtration, the 
solvent was removed by evaporation to give the crude 14 (20 mg) as a pale yellow oil. This 
material used for the next reaction without further purification.  
ESI-TOF-MS m/z [M + H]+ calcd for C92H112N19O10 1642.88; Found 1642.91. 
 
Synthesis of 10 
A mixture of crude 14 (10 mg), DIEA (18 µL, 108 µmol), Oregon Green 488-SE (2.5 mg, 5 
µmol) in dry DMF (2 mL) was stirred for 3 h at rt. The reaction was monitored by reverse-phase 
HPLC. Purification by reverse-phase HPLC and subsequent lyophilization gave 10 (2.4 mg, 11% 
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in two steps) as a yellow powder. The purity of 10 was determined to be > 95% by HPLC analysis 
(UV, l = 220 nm). 
HPLC conditions: column; YMC-pack ODS-A, 250 x 20 mm, mobile phase; CH3CN (containing 
0.1% TFA) / H2O (containing 0.1% TFA) = 5 / 95 (10 min) → 50 / 50 (linear gradient over 50 
min), flow rate; 9.9 mL/min, detection; UV (l = 220 nm). 
ESI-TOF-MS m/z [M + H]+ calcd for C113H120F2N19O16 2037.92; Found 2037.91. 
 
 
 
 
Synthesis of 34 
To a solution of 30 (20 mg, 14 µmol) in dry DMF (1.0 mL) was added DIEA (7 µL, 41 µmol) 
and chloroacetic acid N-hydroxysuccinimidyl ester (4.0 mg, 19 µmol) and the solution was stirred 
for 2 h at rt. After dilution with AcOEt, the solution was washed with saturated NaHCO3 and 
brine followed by drying over Na2SO4. The solvent was removed by evaporation to give crude 34 
(21 mg) as a pale yellow oil. This material used for the next reaction without further purification. 
ESI-TOF-MS m/z [M + H]+ calcd for C83H95ClN19O9 1536.72; Found 1536.72. 
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Synthesis of 35 
A solution of the crude 34 (21 mg) and Pd/C-ethylenediamine complex (10 mg) in MeOH-
CH2Cl2 (1 : 1, 5 mL) was vigorously stirred for 5 h under H2 atmosphere at rt. After filtration, the 
solvent was removed by evaporation to give crude 35 (17 mg) as a pale yellow oil. This material 
used for the next reaction without further purification. 
ESI-TOF-MS m/z [M + H]+ calcd for C83H97ClN17O9 1510.73; Found 1510.74. 
 
Synthesis of 11 
A mixture of the crude 35 (17 mg), DIEA (18 µL, 108 µmol), Oregon Green 488-SE (2.5 mg, 
5 µmol) in dry DMF (1.5 mL) was stirred for 3 h at rt. The reaction was monitored by reverse-
phase HPLC. Purification by reverse-phase HPLC and lyophilization gave 11 (3.3 mg, 13% in 
three steps) as a yellow powder. The purity of 11 was determined to be > 95% by HPLC analysis 
(UV, l = 220 nm). 
HPLC conditions: column; YMC-pack ODS-A, 250 x 20 mm, mobile phase; CH3CN (containing 
0.1% TFA) / H2O (containing 0.1% TFA) = 0 / 100 → 50 / 50 (linear gradient over 50 min), flow 
rate; 9.9 mL/min, detection; UV (l = 220 nm). 
ESI-TOF-MS m/z [M + H]+ calcd for C104H105ClF2N17O15 1905.77; Found 1905.76. 
 
 
 
Synthesis of 12 
A mixture of crude 14 (7.1 mg), DIEA (10 µL, 58 µmol), biotin-SE (9.0 mg, 26 µmol) in dry 
DMF (1 mL) was stirred for 13 h at rt. The reaction was monitored by reverse-phase HPLC. 
Purification by reverse-phase HPLC and lyophilization gave 12 (2.0 mg, 15% in two steps) as a 
colorless powder. The purity of 12 was determined to be > 95% by HPLC analysis (UV, l = 220 
nm). 
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HPLC conditions: column; YMC-pack ODS-A, 250 x 10 mm, mobile phase; CH3CN (containing 
0.1% TFA) / H2O (containing 0.1% TFA) = 5 / 95 (10 min) → 45 / 55 (linear gradient over 40 
min), flow rate; 3.0 mL/min, detection; UV (l = 220 nm). 
ESI-TOF-MS m/z [M + H]3+ calcd for C102H126N21O12S 623.32; Found 624.33. 
 
 
 
Synthesis of 13-4Zn(II) 
   Mono-Sulfo-NHS-Nanogold (purchased from Nanoprobes) (6 nmol) was dissolved in MilliQ 
water (200 µL) and mixed with the solution (200 µL) of the zinc complex 14-4Zn(II) (~ 120 
mmol) in 50 mM HEPES (pH 8.0), in which concentration of 14-4Zn(II) was determined by UV 
absorbance at 280 nm using the measured extinction coefficient (e280 nm = 5170 cm-1M-1). The 
mixture was incubated at rt for 3 h with gentle shaking. The mixture was transferred into a dialysis 
membrane (MWCO: 14,000) and dialyzed (1 h x 3) against 300 mL of 50 mM HEPES (pH 7.2) 
containing 50 µM ZnCl2 at rt to remove the excess of 14-4Zn(II). The conjugation of 14-4Zn(II) 
with the nanogold was confirmed by UV absorbance measurement at 280 nm and 420 nm, in 
which the absorbance ratio (A280 nm / A420 nm = 2.77) of the nanogold and the extinction coefficient 
of 14-4Zn(II) were used to estimate the labeling yield.          
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